Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma—Results from the German Cancer Registry Group
Authors:
- Rüdiger BraunRBRüdiger Braun
- Monika Klinkhammer-SchalkeMKMonika Klinkhammer-Schalke
- Sylke Ruth ZeissigSZSylke Ruth Zeissig
- Kees Kleihus van TolKTKees Kleihus van Tol
- Louisa BolmLBLouisa Bolm
- Kim C. HonselmannKHKim C. Honselmann
- Ekaterina PetrovaEPEkaterina Petrova
- Hryhoriy LapshynHLHryhoriy Lapshyn
- Steffen DeichmannSDSteffen Deichmann
- Thaer S. A. AbdallaTAThaer S. A. Abdalla
- Benjamin HeckelmannBHBenjamin Heckelmann
- Peter BronsertPBPeter Bronsert
Open Access
Abstract
Background: Adenosquamous carcinoma of the pancreas (ASCP) is a rare malignancy and its pathophysiology is poorly understood. Sparse clinical data suggest that clinical outcome and overall survival is worse in comparison to common pancreatic ductal adenocarcinoma (PDAC). Methods: We evaluated clinical outcome and prognostic factors for overall survival of patients with ASCP in comparison to patients with PDAC recorded between 2000 and 2019 in 17 population-based clinical cancer registries at certified cancer centers within the Association of German Tumor Centers (ADT). Results: We identified 278 (0.5%) patients with ASCP in the entire cohort of 52,518 patients with pancreatic cancer. Significantly, more patients underwent surgical resection in the cohort of ASCP patients in comparison to patients with PDAC (p < 0.001). In the cohort of 142 surgically resected patients with ASCP, the majority of patients was treated by pancreatoduodenectomy (44.4%). However, compared to the cohort of PDAC patients, significantly more patients underwent distal pancreatectomy (p < 0.001), suggesting that a significantly higher proportion of ASCP tumors was located in the pancreatic body/tail. ASCPs were significantly more often poorly differentiated (G3) (p < 0.001) and blood vessel invasion (V1) was detected more frequently (p = 0.01) in comparison with PDAC. Median overall survival was 6.13 months (95% CI 5.20–7.06) for ASCP and 8.10 months (95% CI 7.93–8.22) for PDAC patients, respectively (p = 0.094). However, when comparing only those patients who underwent surgical resection, overall survival of ASCP patients was significantly shorter (11.80; 95% CI 8.20–15.40 months) compared to PDAC patients (16.17; 95% CI 15.78–16.55 months) (p = 0.007). ASCP was a highly significant prognostic factor for overall survival in univariable regression analysis (p = 0.007) as well as in multivariable Cox regression analysis (HR 1.303; 95% CI 1.013–1.677; p = 0.039). Conclusions: In conclusion, ASCP showed poorer differentiation and higher frequency of blood vessel invasion indicative of a more aggressive tumor biology. ASCP was a significant prognostic factor for overall survival in a multivariable analysis. Overall survival of resected ASCP patients was significantly shorter compared to resected PDAC patients. However, surgical resection still improved survival significantly.Keywords
Funding Information
- Clinician Scientist School Lübeck (413535489)
- Junior Funding Program of the University of Lübeck (413535489)
This publication has 36 references indexed in Scilit:
- 415 Patients with Adenosquamous Carcinoma of the Pancreas: A Population-Based Analysis of Prognosis and SurvivalJournal of Surgical Research, 2012
- Adenosquamous Versus Adenocarcinoma of the Pancreas: A Population-Based Outcomes AnalysisJournal of Gastrointestinal Surgery, 2010
- Adenosquamous Carcinoma of the Pancreas: A Single-Institution Experience Comparing Resection and Palliative CareJournal of the American College of Surgeons, 2008
- Surgical outcome of adenosquamous carcinoma of the pancreasWorld Journal of Gastroenterology, 2008
- Adenosquamous Carcinoma of the PancreasDigestion, 2005
- Adenosquamous carcinoma of the pancreasCancer, 2003
- Adenosquamous Carcinoma Of The Pancreas: A Clinicopathologic Series Of 25 CasesLaboratory Investigation, 2001
- Adenosquamous Carcinoma of the Pancreas: A Light and Electron Microscopic StudyUltrastructural Pathology, 1982
- Squamous cell carcinoma of the pancreasJournal of Surgical Oncology, 1980
- Cross‐classification and survival characteristics of 5,000 cases of cancer of the pancreasJournal of Surgical Oncology, 1973